Discussant: Penelope Webb
Chair: Helen Farrugia
Unstaged cancer in New Zealand: prevalence, predictors and patient prognosis (#157)
9:00 AM
Impact of weight change and weight cycling on overall and subtype-specific endometrial cancer risk. (#158)
9:15 AM
Obesity and survival in women with ovarian cancer: results from the Australian ovarian cancer study, a systematic review and meta-analysis (#159)
9:30 AM
Factors associated with the use of complementary and lifestyle therapies (CALTs) by long term prostate cancer survivors as a result of their prostate cancer diagnosis (#707)
10:15 AM
Predicting absolute risks for oesophageal adenocarcinoma (#161)
9:45 AM
A method to project prevalence by phase of care for prostate cancer (#162)
10:00 AM